Pfizer heeft toestemming om klinische studies op te starten:
Citaat:
|
MAINZ, Germany, and NEW YORK, USA, April 22, 2020 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) and Pfizer Inc. (NYSE: PFE), have announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the Phase 1/2 clinical trial for BioNTech’s BNT162 vaccine program to prevent COVID-19 infection.
|
https://sciencebusiness.net/network-...vid-19-vaccine
__________________
Those who would give up essential Liberty, to purchase a little temporary Safety, deserve neither Liberty nor Safety. - Ben Franklin
"When you're accustomed to privilege equality feels like oppression."
|